TRUE ACANTHOLYTIC PEMPHIGUS FROM THE STANDPOINT OF PSYCHOSOMATIC MEDICINE: A REVIEW OF THE LITERATURE

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract


Today the problem of correlation of mental disorders and skin diseases is relevant in Russia. Psychosomatic disorders, comorbid true acantholytic pemphigus (pemphigus) and cases of affective disorders are described on this literature review. The relationship between manifestation and exacerbations of pemphigus with psychogenic disorders is shown. Studies investigating quality of life of patients with pemphigus are described. The literature was searched in the following databases: MedLine, PubMed, Concilium Medicum, SCOPUS, Web of Science, LILACS, PEPSIC, Russian State Library, the Sechenov central science medical library.

Full Text

Restricted Access

About the authors

I. Yu Dorozhenok

I.M. Sechenov First Moscow State Medical University; Mental Health Research Centre

Moscow, 119991, Russian Federation; Moscow, 115522, Russian Federation

N. P Teplyuk

I.M. Sechenov First Moscow State Medical University

Moscow, 119991, Russian Federation

Daria G. Katranova

I.M. Sechenov First Moscow State Medical University

Email: dkobra@yandex.ru
Moscow, 119991, Russian Federation
dermatologist, trichologist, postgraduate student of the department of skin and venereal diseases, I.M. Sechenov First Moscow State Medical University, Moscow, 119991, Russian Federation

References

  1. Picardi A., Abeni D. Stressful life events and skin diseases: disentangling evidence from myth. Psychoter. Psychosom. 2001; 70(3): 118-36
  2. Андрющенко А.В. Распространенность и структура психических расстройств в общей медицине. Психические расстройства в общей медицине. 2011; 1: 14-27.
  3. Смулевич А.Б., Иванов О.Л., Львов А.Н., Дороженок И.Ю. Психодерматологические расстройства. Дерматовенерология. Национальное руководство. М.: ГЭОТАР-Медиа; 2013: 406-13.
  4. Дороженок И.Ю. Клинико-терапевтические аспекты расстройств тревожного спектра в дерматологической практике (опыт применения Афобазола). Психиатрия и психофармакотерапия. 2016; 18(1): 29-33.
  5. Иванов О.Л., Львов А.Н., Остришко В.В., Новоселов В.С., Колесников Д.Б. Психодерматология: история, проблемы, перспективы. Российский журнал кожных и венерических болезней. 1999; 2(1): 28-38.
  6. Consoli S., Misery L., Myon E., Martin N. Sensitive skin: psychological effects and seasonal changes. J. Eur. Acad. Dermatol. Venereol. 2007; 2 (5): 620-8.
  7. Mojtabai R. Parental Psychopathology and Childhood Atopic Disorders in the Community. Psychosom. Med. 2005; 67(3): 448-53.
  8. Дороженок И.Ю. Психодерматология (психосоматические аспекты хронических дерматозов). Обзор литературы. Психические расстройства в общей медицине. 2008; 1: 41-7.
  9. Карзанов О.В. Истинная акантолитическая пузырчатка: патогенез, диагностика, лечение. Доктор.Ру. 2008; 39(2): 58-61.
  10. Ayatollahi M., Joubeh S., Mortazavi H., Jefferis R., Ghaderi A. IgG4 as the predominant autoantibody in sera from patients with active state of pemphigus vulgaris. J. Eur. Acad. Dermatol. Venereol. 2004; 18(2): 241-2.
  11. Miletta N., Miller M.E., Lam T., Chung K.K., Hivnor C. The management of pemphigus vulgaris in a burn intensive care unit: a case report and treatment review. J. Burn Care Res. 2014; 35(5): 357-63.
  12. Tsuruta D., Kobayashi H. Recent patents in pemphigus research, prophylaxis, diagnosis and treatment in USA (1988-2006). Recent Pat. Inflamm. Allergy Drug Disov. 2007; 1(1): 77-81.
  13. Вульф К., Джонсон Р., Сюрмонд Д. Дерматология по Томасу Фицпатрику. Атлас-справочник. Пер. с англ. М.: Практика: 2007.
  14. Давиденко Е.Б., Махнева Н.В., Белецкая А.В. Современный взгляд на патогенез и факторы, способствующие развитию аутоиммунной пузырчатки. Клиническая дерматология и венерология. 2013; 3: 4-12.
  15. Потекаев Н.С., Теплюк Н.П., Заборова В.А. Терапия истинной пузырчатки. Клиническая дерматология и венерология. 2004; 4: 11-4.
  16. Вольф К., Голдсмит Л.А., Кац С.И., Джилкрест Б.А., Паллер Э.С., Леффель Д.Дж. Дерматология Фицпатрика в клинической практике. Пер. с англ. М.: Изд. Панфилова; БИНОМ; 2012. т.1: 501.
  17. Aithal V., Kini U., Jayaseelan E. Role of direct immunofluorescence on Tzanck smears in pemphigus vulgaris. Diagn. Cytopathol. 2007; 35(7): 403-7.
  18. Borradori L., Koch P.J., Niessen C.M., Erkeland S., Leusden M.R., Sonnenberg A. The Localization of bullous pemphigoid antigen 180 (BP180) in hemidesmosomes is mediated by its cytoplasmic domain and seems to be regulated by the β4 integrin subunit. J. Cell Biol. 1997; 136(6): 1333-47.
  19. Kalantari M., Molina D.M., Farhadieh M., Vigil A., Morrow W.J., Liang X., et al. Partial evaluation of pemphigus vulgaris autoantibody profile using the protein array technology. J. Invest. Dermatol. 2010; 130 (Suppl. 1): S21.
  20. Marchenko S., Chernyavsky A.I., Arredondo J., Gindi V., Grando S.A. Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology. J. Biol. Chem. 2010; 285(6): 3695-704.
  21. Wohl Y., Brenner S. Pemphigus in Israel - an epidemiological analysis of cases in search of risk factors. Isr. Med. Ass. J. 2003; 5(6): 410-2.
  22. Brandsen R., Brenner S., Frusic Zlotkin M., Michelle B., Tamir A., Milner Y. Circulating pemphigus IgG in families of patients with pemphigus: comparison of indirect immunofluorescence, direct immunofluorescence, and immunoblotting. J. Am. Acad. Dermatol. 1997; 36(1): 44-52.
  23. Махнева Н.В., Молочков В.А., Белецкая Л.В. Медикаментозная пузырчатка. Российский журнал кожных и венерических болезней. 2004; 7(3): 14-8
  24. Da Silva K., Mandel L. Early manifestation of pemphigus vulgaris: A case report. N. Y. State Dent. J. 2007; 73(3): 42-4.
  25. Fujita H., Iguchi M., Watanabe R., Asahina A. Pemphigus foliaccus induced by bucillamine. Eur. J. Dermatol. 2007; 17(1): 98-9.
  26. Cummins D.L., Mimouni D., Tzu J., Owens N., Anhalt G.J., Meyerle J.H. Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies. J. Am. Acad. Dermatol. 2007; 56(1): 153-9.
  27. Wallis S., Lloyd S., Wise I., Ireland G., Fleming T.P., Garrod D. The alpha isoform of protein kinase C is involved in signaling the response of desmosomes to wounding in cultured epithelial cells. Mol. Biol. Cell. Mar 2000; 11(3): 1077-92.
  28. Woldegiogis S., Swerlick R.A. Pemphigus in the southeastern United States. South Med. J. 2001; 94(7): 694-8.
  29. Brenner S., Wolf R., Ruocco V. Drug-induced pemphigus: a survey. Clin. Dermatol. 1993; 11(4): 501-5.
  30. Uzun S., Murat D., Akman A., Gunasti S., Uslular C., Memisoglu H.R., Alpsoy E. Pemphigus in the Mediterranean region of Turkey: a study of 148 cases. Int. J. Dermatol. 2006; 45(5): 523-8.
  31. Чернуха А.М., Фролов Е.П., ред. Кожа (строение, функция, общая патология и терапия). М.: Медицина; 1982.
  32. Дибривная К.А., Мельников М.В., Бойко О.В., Хачанова Н.В., Бойко А.Н. Побочные эффекты терапии глюкокортикостероидами при рассеянном склерозе: описание клинического случая с глобальной амнезией. Журнал неврологии и психиатрии. 2014; 2(Вып. 2): 83-6.
  33. Лыкова С.Г., Решетникова Т.Б., Спицина А.В. ИАП: патогенетические механизмы и особенноси кортикостероидной терапии. Сибирский журнал дерматологии и венерологии. 2001; 1: 9-13.
  34. Silvares M.R., Fortes M.R., Miot H.A. Quality of life in chronic urticaria: a survey at a public university outpatient clinic, Botucatu (Brazil). Rev. Assoc. Med. Bras. 2011; 57(5): 577-82.
  35. Silva M.F., Fortes M.R., Miot L.D., Marques S.A. Psoriasis: correlation between clinical severity (PASI) and quality of life index (DLQI) in patients assessed before and after systemic treatment. An. Bras. Dermatol. 2013; 88(5): 760-3.
  36. Taborda M.L., Weber M.B., Teixeira K.A., Lisboa A.P., Welter Ede Q. Evaluation of the quality of life and psychological distress of patients with different dermatoses in a dermatology referral center in southern Brazil. An. Bras. Dermatol. 2010; 85(1): 52-6.
  37. Bobko S.I., Teplyuk N.P., Valotova J.V., Lvov A.N. Nosogenic reactions in patients with bullous dermatoses. 13th Congress of the European Society for Dermatology and Psychiatry. Acta. Dermat. Venerol. 2009; 89(Issue 5): 563-4. https://www.medicaljournals.se/acta/content/abstract/10.2340/00015555-0727
  38. Mayrshofer F., Hertl M., Sinkgraven R., Sticherling M., Pfeiffer C., Zillikens D., et al.; Rzany Für Die Deutschebsd-Studiengruppe B. Significant decrease in quality of life in patients with pemphigus vulgaris. Results from the German Bullous Skin Disease (BSD) Study Group. J. Dtsch. Dermatol. Ges. 2005; 3(6): 431-5.
  39. Tabolli S., Mozzetta A., Antinone V., Alfani S., Cianchini G., Abeni D. The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36-item short form health survey questionnaire. Br. J. Dermatol. May 2008; 158(5): 1029-34.
  40. Paradisi A., Sampogna F., Di Pietro C., Cianchini G., Didona B., Ferri R., Abeni D., Tabolli S. Quality-of-life assessment in patients with pemphigus using a minimum set of evaluation tools. J. Am. Acad. Dermatol. 2009; 60(2): 261-9.
  41. Terrab Z., Benckikhi H. Maaroufi A., Hassoune S., Amine M., Lakhdar H. Quality of life and pemphigus. Ann. Dermatol. Venereol. 2005; 132(4): 321-8.
  42. Arbabi M., Ghodsi Z., Mahdanian A., Noormohammadi N., Shalileh K., Darvish F., et al. Mental health in patients with pemphigus: an issue to worth consideration. Indian J. Dermatol. 2011; 56(5): 541-5.
  43. Sung J.Y., Roh M.R., Kim S.C. Quality of life assessment in Korean patients with pemphigus. Ann. Dermatol. 2015; 27(5): 492-8.
  44. Noorbala A.A., Bagheri Yazdi S.A., Yasamy M.T., Mohammad K. Mental health survey of the adult population in Iran. Br. J. Psychiatry. 2004; 184: 70-3.
  45. Pallanti S., Lotti T., Urpe M. Psychoneuroimmunodermatology of atopic dermatitis: from empiric data to the evolutionary hypothesis. Dermatol. Clin. 2005; 23(4): 695-701.
  46. Cremniter D., Baudin M., Roujeau J.C., Prost C., Consoli S.G., Francуs C., et al. Stressful Life Events as Potential Triggers of Pemphigus. Arch. Dermatol. 1998; 134(11): 1486-7.
  47. Perry H.O., Brunsting L.A. Pemphigus foliaceus. Arch. Dermatol. Jan 1965; 91: 10-23.
  48. Brenner S., Bar-Nathan E.A. Pemphigus vulgaris triggered by emotional stress. J. Am. Acad. Dermatol. 1984; 11(3): 524-5.
  49. Srebrnik A., Brenner S. Pemphigus vulgaris and stress: a psychological evaluation of 17 cases. Dermatol. Psychosomat. 2001; 2(4): 191-4.
  50. Sustic N., Rucevic I., Barisic-Drusko V. Epidemiology of acquired bullous diseases in Eastern Croatia: a retrospective prewar to postwar study. Acta. Dermatovenerol. Croat. Mar 2005; 13(4): 228-32.
  51. Morell-Dubois S., Carmmiter O., Cottencin O., Queyrel V., Hachulla E., Hatron P.Y., Delaporte E. Stressful life events and pemphigus. Dermatology. 2008; 216(2): 104-8.
  52. Ткаченко С.Б., Теплюк Н.П., Алленова А.С., Лепехова А.А. К вопросу о классификации буллезных дерматозов. Российский журнал кожных и венерических болезней. 2015; 18(2): 13-6
  53. Ragab N., Abdallah M., El-Gohary E., Elewa R. Stress and serum TNF-alpha levels may predict disease outcome in patients with pemphigus: a preliminary study. Cutis. 2011; 87(4): 189-94.
  54. Wohl Y., Mashiah J., Kutz A., Hadj-Rabia S., Cohen A.D. Pemphigus and depression comorbidity: a case control study. Eur. J. Dermatol. 2015; 25(6): 602-5.
  55. Kumar V., Mattoo S.K., Handa S. Psychiatric morbidity in pemphigus and psoriasis: a comparative study from India. Asian J. Psychiatr. 2013; 6(2): 151-6.
  56. Gupta M.A., Lanius R.A., Van der Kolk B.A. Psychologic trauma, posttraumatic stress disorder, and dermatology. Dermatol. Clin. 2005; 23(4): 649-56.
  57. Layegh P., Mokhber N., Javidi Z., Mashhadi M.P., Moghiman T. Depression in patients with pemphigus: is it a major concern? J. Dermatol. 2013; 40(6): 434-7.
  58. Beqqal K., Chau E., Senouci K., Ouahid W., Benzekri L., Hassam B., Belgnaoui F., Pemphigus and steroid psychosis: a case report and review of literature. Clin. Pathol. 2014; 1(2): 101-4. http://www.sciedupress.com/journal/index.php/crcp/article/view/4186/2800
  59. Barrimi M., Aalouane R., Aarab C., Hafidi H., Baybay H., Soughi M., et al. Prolonged corticosteroid-therapy and anxiety-depressive disorders, longitudinal study over 12 months. Encephale. 2013; 39(1): 59-65.
  60. Коркина М.В., Лакосина Н.Д., Личко А.Е. Психиатрия. М.: Медицина; 1995: 501-12
  61. Minden S.L., Orav J., Schildkraut J.J. Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis. Neurology.1988; 38(10): 1631-4

Statistics

Views

Abstract - 17

PDF (Russian) - 0

Cited-By


Article Metrics

Metrics Loading ...

PlumX

Dimensions


Copyright (c) 2017 Dorozhenok I.Y., Teplyuk N.P., Katranova D.G.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies